Testing the Efficacy and Safety of the WEI Nasal Jet (WNJ)

Zeyong Yang

Status: Completed

Conditions: Complication of Surgical Procedure

Treatments: Device: Experimental group and control groupl

Study type: Observational

Funder types: Other

Identifiers

NCT02005406

Wei JET

Details and patient eligibility

About

Testing the efficacy and safety of the WEI Nasal Jet.

Full description

This is only initial thought and suggestions from the inventor Dr. Huafeng Wei. Principal investigator from each medical center interested in testing this new device should design their own clinical trials based on patient population and their own ideas for clinical trials. Just remind you that patient safety is number one and try all efforts to minimize patient risks during your clinical study.

Enrollment: 49 patients

Sex: All

Ages: 22 to 58 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients receiving various types of surgeries under sedation, especially for procedures of colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography (ERCP) cystoscopy and other brief surgeries you are interested in the study.

Exclusion criteria

• Patients with coagulopathy and tendency of nose bleeding.
• Patients with any diagnosed cardiac diseases (e.g. cardiac failure, angina, MI, cardiac arrhythmia. etc.)
• Patients with any diagnosed pulmonary disease (e.g. asthma, COPD, pulmonary embolism, pulmonary edema etc.)
• Pregnant patients
• Patients with liver failure
• Patients with kidney failure

Trial design

49 participants in 1 patient group

wei group and control group

Description:

wei group(n=25) and control group(n=24)

Treatment:

Device: Experimental group and control groupl